Christopher McGuigan
39Patents
17h-index
45Co-inventors
81Inventor score
Filing activity: Aug 24, 1999 → Jan 11, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7951787B2 | Phosphoramidate compounds and methods of use | Human Necessities | 97 | Active |
| US6455513B1 | Chemical compounds | Chemistry; Metallurgy | 95 | Expired |
| US7414036B2 | Compounds useful as A3 adenosine receptor agonists | Human Necessities | 90 | Expired |
| US7018989B2 | Chemical compounds | Chemistry; Metallurgy | 79 | Expired |
| US7608599B2 | Antiviral phosphoramidates | Chemistry; Metallurgy | 64 | Active |
| US8759318B2 | Phosphoramidate derivatives of guanosine nucleoside compounds for treatment of viral infections | Chemistry; Metallurgy | 55 | Active |
| US8658616B2 | Nucleoside aryl phosphoramidates and their use as anti-viral agents for the treatment of hepatitis C virus | Human Necessities | 43 | Active |
| US6573247B1 | Anti-viral pyrimidine nucleoside analogues | Chemistry; Metallurgy | 32 | Expired |
| USRE47589E1 | Phosphoramidate compounds and methods of use | General | 32 | Active |
| US6638919B2 | Antiviral purine derivatives | Human Necessities | 29 | Expired |
| US7019135B2 | Anti-viral pyrimidine nucleoside analogues | Chemistry; Metallurgy | 29 | Expired |
| US7820631B2 | Anti-viral pyrimidine nucleoside analogues | Chemistry; Metallurgy | 28 | Expired |
| US8119779B2 | Phosphoramidate derivatives | Emerging Cross-Sectional Technologies | 27 | Active |
| US8933053B2 | Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine for use in the treatment of cancer | Chemistry; Metallurgy | 24 | Active |
| US7115590B1 | Phosphoramidate, and mono-, di-, and tri-phosphate esters of (1R, cis)-4-(6-amino-9H-purin-9-yl)-2-cyclopentene-1-methanol as antiviral agents | Human Necessities | 24 | Expired |
| US9221866B2 | Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine for use in the treatment of cancer | Chemistry; Metallurgy | 18 | Active |
| US8263575B2 | Phosphoramidate derivatives of nucleoside compounds for use in the treatment of cancer | Human Necessities | 18 | Active |
| US9655915B2 | Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine for use in the treatment of cancer | Chemistry; Metallurgy | 14 | Active |
| US10022390B2 | Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine for use in the treatment of cancer | Chemistry; Metallurgy | 13 | Active |
| US10993957B2 | Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine for use in the treatment of cancer | Chemistry; Metallurgy | 4 | Active |
| US9321798B2 | Phosphoramidite derivatives of gemcitabine for use in the treatment of cancer | Human Necessities | 4 | Active |
| US10570168B2 | 2′ and/or 5′ amino-acid ester phosphoramidate 3′-deoxy adenosine derivatives as anti- cancer compounds | Chemistry; Metallurgy | 4 | Active |
| US8329664B2 | Anti-viral pyrimidine nucleoside derivatives | Human Necessities | 3 | Active |
| US10662213B2 | Gemcitabine prodrugs | Human Necessities | 3 | Active |
| US10906929B2 | Phosphoramidate nucleoside derivatives as anticancer agents | Chemistry; Metallurgy | 2 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.